2019 Clinical Chemistry and Immunodiagnostic: Innovative Technologies and Strategic Profiles of Leading Suppliers

February 2019 | 145 pages | ID: 25BC50CFBFFEN
Venture Planning Group

Abstracts

This 145-page report reviews potential market applications of current and emerging clinical chemistry and immunodiagnostic technologies, including monoclonal and polyclonal antibodies, immunoassays, IT, dry chemistry, biosensors, robotics, molecular diagnostics and others.

The report also presents strategic assessments of current and emerging suppliers of clinical chemistry and immunodiagnostic products, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.

Contains 145 pages

Contents

CURRENT AND EMERGING TECHNOLOGIES

Monoclonal and Polyclonal Antibodies
Immunoassays
  a. Technological Principle
  d. Chemiluminescence
  c. Enzyme Immunoassays (EIA)
    Overview
    ELISA
    EMIT
    Electrochemical
  d. Radioimmunoassays (RIA)
  e. Immunoprecipitation
  f. Affinity Chromatography
IT and Automation
Dry Chemistry
Biosensors
Robotics
Molecular Diagnostics
  a. Detection Technologies
    1. Radioactive Methods
    2. Non-Isotopic Methods
  b. Instrumentation Review
Abbott LCX
BeckmanCoulter/Biomek FX
Becton Dickinson
Bio-Rad Gene Scope
Gen-Probe
Roche Cobas Amplicor
#Tecan LS Series
  c. Biochips Genosensor, Microarrays, Labs-on-the-Chips
Chemometrics

COMPETITIVE PROFILES

Abbott Laboratories
AdnaGen/Alere
Agilent Technologies
Bayer Healthcare
Beckman Coulter/Danaher
Biomedical Diagnostics
BioMerieux
Bio-Rad
DiaSorin
Eiken
Fujirebio
Grifols
Instrumentation Laboratory
Kyowa Medex
Matritech
Ortho-Clinical Diagnostics
Roche
Siemens
Sysmex
Thermo Fisher
Tosoh
Wako
Wallac/PE